SMS Pharmaceuticals Limited has informed the Exchange about General Updates
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has informed exchanges that an operational creditor, M/s. Sai Sreyas Pharmaceutical Private Limited, has filed a petition under Section 9 of the Insolvency and Bankruptcy Code (IBC) before the NCLT Hyderabad Bench. The petition alleges a default of ₹3.02 Crores in unpaid operational debt and seeks initiation of Corporate Insolvency Resolution Process (CIRP) against the company. The NCLT has registered the matter on 25.06.2025. The company disputes the claim, citing quality issues with materials supplied by the petitioner and had previously asked them to take back the disputed material. The company is seeking legal advice and intends to contest the petition to protect its interests.
This is a negative development for shareholders as it raises the prospect of insolvency proceedings against the company. However, the petition is only at the registration stage and has not been admitted yet, and the company is actively contesting it. Investors should monitor further updates on the NCLT proceedings as admission of the petition could lead to significant disruption.